Cargando…
Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest
Several population groups display an increased risk of severe disease and mortality following SARS-CoV-2 infection. These include those who are immunocompromised (IC), have a cancer diagnosis, human immunodeficiency virus (HIV) infection or chronic inflammatory disease including autoimmune disease,...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135663/ https://www.ncbi.nlm.nih.gov/pubmed/35718592 http://dx.doi.org/10.1016/j.vaccine.2022.05.067 |